A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy.
Bergsagel
P L
PL
D049109:Cell Proliferation; D002869:Chromosome Aberrations; D020732:Cytogenetic Analysis; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D007621:Karyotyping; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D012074:Remission Induction